Collecting repeated blood samples to study treatment resistance
Part of Blood & lymphatic, Cancer clinical trials.
This study collects blood samples over time from adults with certain blood cancers to better understand why treatments stop working. It may help researchers improve how future therapies are chosen for patients whose disease becomes resistant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these diagnoses: acute leukemia, myelodysplastic syndrome, chronic myelomonocytic leukemia, or a myeloproliferative blood disorder
- You are starting a new treatment plan (a new line of therapy)
- You are 18 years or older
- You can give legal consent to join
- You weigh at least 50 kg
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how different blood cancers and early (pre-cancer) blood conditions work, using tumor/blood tissue samples. It may help researchers learn more about disease biology for future treatments, with little to no extra risk if samples come from routine care.
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
This trial collects tissue, blood, and other body fluid samples from people with blood-related cancers. The goal is to help researchers study these diseases by building a source of samples for future testing.
This study follows people who are newly diagnosed (and haven’t been fully treated yet) with specific leukemia or related blood disorders to help researchers learn which treatments may work best. It may help by connecting you to a larger “precision medicine” patient group for future research.
This study is for adults with acute myeloid leukemia (AML) whose cancer has returned or is not responding to treatment. Researchers will analyze your leukemia cells to learn more about the disease and possibly find better treatments.
This study asks healthy adults to provide blood, bone marrow (if needed), skin, saliva, and stool samples. Scientists use these samples to compare patterns related to myeloid (bone-marrow) blood cancers, which may help future research and tests.
Hear when a new Hematologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.